Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease

• Main Author: O.O. Melnyk
• Format: Article
• Language: English
• Published: Publishing House Zaslavsky 2016-04-01
• Series: Počki
• Subjects: chronic kidney disease; cholesterol; triglycerides; low density lipoproteins; high density lipoproteins; apo AI; apo AII; lipoprotein lipase; hepatic triglyceride lipase; statins; fibrates; nicotinic acid
• Online Access: http://kidneys.zaslavsky.com.ua/article/view/72751

Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid-modifying drugs — statins, fibrates, nicotinic acid was proposed.